The stock's overall trend over the past six months shows significant volatility, declining 4.97% from October 2025 to March 2026. It reached a high near $68 in early January 2026 before a sharp correction. Short-term performance has been mixed, with the stock up 2.65% over the past month but down 18.22% over the past three months. This recent monthly gain occurred amidst a broader market decline, as indicated by a positive 1-month relative strength of 7.90 against the S&P 500. The current price of $53.10 sits near the middle of its 52-week range of $43.18 to $68.18, representing a recovery from recent lows but still well below its peak. No RSI data was provided for further momentum analysis.

Revenue growth has been modest, with Q2 2026 revenue of $5.18B representing a 2.05% year-over-year increase. Profitability has been inconsistent; the net margin for that quarter was 4.42%, a significant drop from the 16.02% margin in Q1 2026, indicating quarterly volatility in earnings. The company maintains a strong current ratio of 2.91 and a manageable debt-to-equity ratio of 0.62, suggesting solid liquidity and a reasonable capital structure. Free cash flow over the trailing twelve months is positive at $2.54B, supporting financial flexibility. Return on Equity (ROE) is a healthy 18.92%, indicating efficient use of shareholder capital. However, the latest quarterly data shows a lower asset turnover, reflecting potential challenges in generating revenue from its asset base during that period.